EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cross-population proteome-wide mendelian randomization study identifies likely causal proteins for cardiovascular diseases

Hua Zhong, Jingjing Zhu, Shuai Liu, Hoi Tung Hilton Wong, Yiqiang Zhang, Hung N Luu, Qing Wu, Xuexia Wang, Lang Wu

Molecular Genetics and Genomics · 2026-12 · 301 (1)

DOI: 10.1007/s00438-026-02458-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics and Genomics, online erschienen am 03.08.2026. Verfasst von Hua Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Oncology, LSU-LCMC Health Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New O…. Hauptthemen laut MEDLINE: Blood Proteins, Cardiovascular Diseases, Mendelian Randomization Analysis, Proteome. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Cancer Epidemiology and Genetics, National Cancer Institute, UCLA LIFT-UP, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood proteins may play causal roles in cardiovascular diseases (CVDs) such as heart failure (HF) and peripheral artery disease (PAD). Proteome-wide Mendelian randomization (MR) has been widely used to prioritize drug targets for CVD in European populations, but its application to non-European populations remains limited. We conducted a proteome-wide MR analysis to evaluate the potential causal effects of 2,922 plasma proteins on five CVDs—atrial fibrillation (AF), coronary artery disease (CAD), HF, ischemic heart disease (IHD), and PAD. Analyses were performed across African (n = 931), East Asian (n = 262), and European (n = 10,840) populations using genetic instrument data from the UK Biobank cohort. Significant associations were further examined with genetic colocalization to strengthen causal inference. Using MR and colocalization analyses, we identified 53 significant protein–CVD associations across multi-populations, including 16 in African, six in East Asian, and 31 in European populations, respectively. Cross-population comparisons revealed four protein–CVD associations unique to African population and another four specific to East Asian population. Integration with clinical trial data prioritized 14 protein–disease pairs as promising candidates for therapeutic development or drug repurposing. Our findings highlight the value of proteome-wide MR in evaluating drug target applicability across populations. Several protein–disease associations were population-specific, emphasizing the need for inclusive genetic research to inform precision medicine in CVD prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood ProteinsCardiovascular DiseasesMendelian Randomization AnalysisProteomeHumansGenetic Predisposition to DiseaseGenome-Wide Association StudyPolymorphism, Single NucleotideEast Asian PeopleBlack PeopleWhite People

Stichwörter der Autor:innen

Cardiovascular diseasesDifferent populationsDrug targetsProteomeTwo-sample Mendelian randomization

Substanzen

Blood ProteinsProteome

Autor:innen und Institutionen

  • Department of Interdisciplinary Oncology, LSU-LCMC Health Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Department of Genetics, LSU-LCMC Health Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, HI, USA.
  • Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, USA.
  • Biochemistry Program, Department of Chemistry, Colleges of Arts and Sciences, University of Hawai'i at Mānoa, Honolulu, HI, USA.
  • Department of Anatomy, Biochemistry and Physiology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, USA.

Förderung

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute
  • UCLA LIFT-UP
  • NHGRI NIH HHS
  • National Human Genome Research Institute

Zitieren

APA

Zhong, H., Zhu, J., Liu, S., Wong, H. T. H., Zhang, Y., Luu, H. N., Wu, Q., Wang, X., & Wu, L. (2026). Cross-population proteome-wide mendelian randomization study identifies likely causal proteins for cardiovascular diseases. Molecular Genetics and Genomics, 301(1). https://doi.org/10.1007/s00438-026-02458-4

Vancouver

Zhong H, Zhu J, Liu S, Wong HTH, Zhang Y, Luu HN, et al. Cross-population proteome-wide mendelian randomization study identifies likely causal proteins for cardiovascular diseases. Molecular Genetics and Genomics. 2026;301(1). doi:10.1007/s00438-026-02458-4

BibTeX
@article{Zhong2026,
  author = {Zhong, Hua and Zhu, Jingjing and Liu, Shuai and Wong, Hoi Tung Hilton and Zhang, Yiqiang and Luu, Hung N and Wu, Qing and Wang, Xuexia and Wu, Lang},
  title = {Cross-population proteome-wide mendelian randomization study identifies likely causal proteins for cardiovascular diseases},
  journal = {Molecular Genetics and Genomics},
  year = {2026},
  volume = {301},
  number = {1},
  doi = {10.1007/s00438-026-02458-4}
}
Kostenlos starten →